Home » Topics » Regulatory

Regulatory
RSS

Ethyol approved by FDA for radiation-induced dry mouth

June 28, 1999

HIV protease inhibitor Agenerase now available in oral solution

June 28, 1999

Olanzapine effective in management of bipolar disorder

June 28, 1999

Bristol-Myers Squibb files for FDA approval of Taxol/Herceptin combination

June 25, 1999

Daclizumab may have applications in uveitis therapy

June 25, 1999

FDA clears Cutivate cream for treatment of atopic dermatitis in children

June 25, 1999

Copley launches first controlled drug

June 24, 1999

U.K. is first market for new formulation of Casodex

June 23, 1999

Botox is not effective in treating whiplash injury

June 17, 1999

Two research teams reach the same conclusion: topiramate is a promising antimigraine agent

June 17, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 11, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 11, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.